Is There An Opportunity In Medline (MDLN) After Recent DCF Valuation Results

Simply Wall St.01-18

If you are wondering whether Medline is offering fair value at its current price, this article walks you through what the numbers are saying and what that could mean for you. Medline shares recently ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2604927905?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155","is_english":true,"pubTime":"2026-01-18 13:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2604927905","market":"nz","top_or_hot":-1,"title":"Is There An Opportunity In Medline (MDLN) After Recent DCF Valuation Results","media":"Simply Wall St.","content":"<div>\n<p>If you are wondering whether Medline is offering fair value at its current price, this article walks you through what the numbers are saying and what that could mean for you. Medline shares recently ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-mdln/medline/news/is-there-an-opportunity-in-medline-mdln-after-recent-dcf-val\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is There An Opportunity In Medline (MDLN) After Recent DCF Valuation Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs There An Opportunity In Medline (MDLN) After Recent DCF Valuation Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-18 13:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-mdln/medline/news/is-there-an-opportunity-in-medline-mdln-after-recent-dcf-val><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If you are wondering whether Medline is offering fair value at its current price, this article walks you through what the numbers are saying and what that could mean for you. Medline shares recently ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-mdln/medline/news/is-there-an-opportunity-in-medline-mdln-after-recent-dcf-val\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MDLN","symbol_name":"Medline Inc","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-mdln/medline/news/is-there-an-opportunity-in-medline-mdln-after-recent-dcf-val","article_id":"2604927905","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-mdln/medline/news/is-there-an-opportunity-in-medline-mdln-after-recent-dcf-val","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2604927905","pubTimestamp":1768713671,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"If you are wondering whether Medline is offering fair value at its current price, this article walks you through what the numbers are saying and what that could mean for you.\nMedline shares recently closed at US$44.12, with returns of 8.9% over the last 7 days, 5.9% over the last 30 days, and 8.6% year to date, which has put the stock on more investors' radar.\nRecent company updates and sector commentary around medical suppliers have given investors more information to work with, which can...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"MDLN":"Medline Inc","DCF":"Dreyfus Alcentra Global Credit Income 2024 Target Term Fund, Inc","BK4198":"医疗保健用品"},"translate_title":"在最近的DCF估值结果之后，Medline(MDLN)是否存在机会","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DCF":1.5,"MDLN":1.5},"content_text":"If you are wondering whether Medline is offering fair value at its current price, this article walks you through what the numbers are saying and what that could mean for you. Medline shares recently closed at US$44.12, with returns of 8.9% over the last 7 days, 5.9% over the last 30 days, and 8.6% year to date, which has put the stock on more investors' radar. Recent company updates and sector commentary around medical suppliers have given investors more information to work with, which can influence how they think about the stock's risk and potential. These developments help explain why shorter term returns look different from the longer term data that is not yet available. On our valuation checklist Medline scores 4 out of 6, suggesting several pricing metrics look appealing. Next, we will walk through the main valuation methods, then finish with a way to judge value that many investors find even more useful than the raw ratios.  Medline delivered 0.0% returns over the last year. See how this stacks up to the rest of the Medical Equipment industry. AdvertisementApproach 1: Medline Discounted Cash Flow (DCF) Analysis A Discounted Cash Flow model starts with cash flow projections, then discounts those future dollars back into today’s terms to estimate what the business might be worth right now. For Medline, the latest twelve month Free Cash Flow is about $1.06b. Analysts and model estimates project Free Cash Flow rising to $2.96b by 2030, with a series of annual projections in between. Simply Wall St uses analyst inputs where available, then extends the forecasts using its own assumptions to build a 2 Stage Free Cash Flow to Equity model. When all those future cash flows are discounted back to today, the model arrives at an estimated intrinsic value of US$62.51 per share. Compared with the recent share price of US$44.12, this implies the stock is trading at a 29.4% discount to that DCF estimate. On this cash flow based view, Medline appears undervalued using this model. Result: UNDERVALUED Our Discounted Cash Flow (DCF) analysis suggests Medline is undervalued by 29.4%. Track this in your watchlist or portfolio, or discover 873 more undervalued stocks based on cash flows. MDLN Discounted Cash Flow as at Jan 2026 Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Medline. Approach 2: Medline Price vs Earnings For a profitable company like Medline, the P/E ratio is a useful way to think about value because it links what you pay today to the earnings the business is already generating. A higher or lower P/E often reflects what the market is pricing in for future growth and how much risk investors feel they are taking on. In simple terms, stronger earnings growth and lower perceived risk usually justify a higher, or “richer”, P/E ratio, while slower growth or higher risk tend to line up with a lower P/E. Medline currently trades on a P/E of 29.0x. That sits below the Medical Equipment industry average of about 31.2x and also below the peer group average of roughly 31.5x, so the market is assigning Medline a lower multiple than these broader groups. Simply Wall St also looks at a proprietary “Fair Ratio”, which is the P/E it would expect for Medline after taking into account factors like its earnings profile, industry, profit margins, market cap and company specific risks. This Fair Ratio can give a more tailored view than a simple industry or peer comparison because it adjusts for differences rather than assuming all companies deserve the same multiple. In this case, the Fair Ratio is not available, so it is not possible to draw a firm conclusion on whether Medline’s current 29.0x P/E is overvalued, undervalued or about right on this basis. Result: ABOUT RIGHT NasdaqGS:MDLN P/E Ratio as at Jan 2026 P/E ratios tell one story, but what if the real opportunity lies elsewhere? Discover 1442 companies where insiders are betting big on explosive growth. Upgrade Your Decision Making: Choose your Medline Narrative Earlier we mentioned that there is an even better way to understand valuation, so let us introduce you to Narratives, which are simply your own story about Medline, tied to what you think its future revenue, earnings and margins could look like, and the fair value that flows from those assumptions. On Simply Wall St’s Community page, used by millions of investors, you can pick or create a Medline Narrative that connects the company’s story to a financial forecast, which then links directly to an estimated fair value in a way that is far easier to work with than raw ratios alone. Narratives help you decide what to do by setting that fair value next to today’s share price, so you can quickly see whether your story suggests Medline might be cheap, expensive or roughly in line with your expectations, and they automatically refresh when new information such as news or earnings is added to the platform. For example, one Medline Narrative on Simply Wall St might assume a relatively cautious outlook and arrive at a lower fair value, while another assumes stronger business performance and reaches a higher fair value, giving you a clear view of how different perspectives translate into different price signals. Do you think there's more to the story for Medline? Head over to our Community to see what others are saying! NasdaqGS:MDLN 1-Year Stock Price Chart  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2604927905","isCrawlerRequest":true}